Subjects With T2D or at Risk of T2D Cohort Follow-up

NCT ID: NCT05567692

Last Updated: 2025-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

837 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-10

Study Completion Date

2032-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to prospectively follow the subjects included in "Descendance" cohort and to describe the occurrence of type 2 diabetes in non-diabetic subjects, which will allow us to iteratively update the "Descendance" Type 2 Diabetes risk prediction model.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

High risk families will be prospectively follow in order to better understand the risk of transmission of type 2 diabetes from one generation to another. The cohort will also allow us to collect additional data on diabetic patients.

The monitoring of the cohort will take place for at least 10 years with a follow-up of all participants every three years. To detect individuals who develop dysglycemia during the study, a glucose tolerance test (GTT) and HbA1c measurement will be conducted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

T2D group

subjects with type 2 diabetes

Questionnaire

Intervention Type OTHER

Follow-up questionnaire

Non-T2D group

healthy subjects

OGTT

Intervention Type DIAGNOSTIC_TEST

Oral Glucose Tolerance Test

HbA1c

Intervention Type OTHER

HbA1c measurement

Questionnaire

Intervention Type OTHER

Follow-up questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OGTT

Oral Glucose Tolerance Test

Intervention Type DIAGNOSTIC_TEST

HbA1c

HbA1c measurement

Intervention Type OTHER

Questionnaire

Follow-up questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects have participated in the Descendance study
* Subjets who sign informed consent to participate in the study

Exclusion Criteria

* Subjects not enrolled in Descendance study
* Subjects refusing to participate
* Pregnant or breastfeeding
* Subjects in emergency situations, under legal protection or unable to provide informed -consent
* Subjects lost to follow-up or died
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Pasteur de Lille

OTHER

Sponsor Role collaborator

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillaume CHARPENTIER, Dr

Role: PRINCIPAL_INVESTIGATOR

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Évry, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A01538-35

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.